Authors:
Robey, RW
Medina-Perez, WY
Nishiyama, K
Lahusen, T
Miyake, K
Litman, T
Senderowicz, AM
Ross, DD
Bates, SE
Citation: Rw. Robey et al., Overexpression of the ATP-binding cassette half-transporter, ABCG2 (MXR/BCRP/ABCP1), in flavopiridol-resistant human breast cancer cells, CLIN CANC R, 7(1), 2001, pp. 145-152
Authors:
Bailey-Dell, KJ
Hassel, B
Doyle, LA
Ross, DD
Citation: Kj. Bailey-dell et al., Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene, BBA-GENE ST, 1520(3), 2001, pp. 234-241
Authors:
Erlichman, C
Boerner, SA
Hallgren, CG
Spieker, R
Wang, XY
James, CD
Scheffer, GL
Maliepaard, M
Ross, DD
Bible, KC
Kaufmann, SH
Citation: C. Erlichman et al., The HER tyrosine kinase inhibitor CI1033 enhances cytotoxicity of 7-ethyl-10-hydroxycamptothecin and topotecan by inhibiting breast cancer resistanceprotein-mediated drug efflux, CANCER RES, 61(2), 2001, pp. 739-748
Authors:
Kawabata, S
Oka, M
Shiozawa, K
Tsukamoto, K
Nakatomi, K
Soda, H
Fukuda, M
Ikegami, Y
Sugahara, K
Yamada, Y
Kamihira, S
Doyle, LA
Ross, DD
Kohno, S
Citation: S. Kawabata et al., Breast cancer resistance protein directly confers SN-38 resistance of lungcancer cells, BIOC BIOP R, 280(5), 2001, pp. 1216-1223
Citation: Dd. Ross et Cs. Alexander, Management of common symptoms in terminally ill patients: Part II. Constipation, delirium and dyspnea, AM FAM PHYS, 64(6), 2001, pp. 1019-1026
Citation: Dd. Ross et Cs. Alexander, Management of common symptoms in terminally ill patients: Part I. Fatigue,anorexia, cachexia, nausea and vomiting, AM FAM PHYS, 64(5), 2001, pp. 807-814
Authors:
Litman, T
Brangi, M
Hudson, E
Fetsch, P
Abati, A
Ross, DD
Miyake, K
Resau, JH
Bates, SE
Citation: T. Litman et al., The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2), J CELL SCI, 113(11), 2000, pp. 2011-2021
Authors:
Volk, EL
Rohde, K
Rhee, M
McGuire, JJ
Doyle, LA
Ross, DD
Schneider, E
Citation: El. Volk et al., Methotrexate cross-resistance in a mitoxantrone-selected multidrug-resistant MCF7 breast cancer cell line is attributable to enhanced energy-dependent drug efflux, CANCER RES, 60(13), 2000, pp. 3514-3521
Authors:
Scheffer, GL
Maliepaard, M
Pijnenborg, ACLM
van Gastelen, MA
de Jong, MC
Schroeijers, AB
van der Kolk, DM
Allen, JD
Ross, DD
van der Valk, P
Dalton, WS
Schellens, JHM
Scheper, RJ
Citation: Gl. Scheffer et al., Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone- and topotecan-resistant cell lines, CANCER RES, 60(10), 2000, pp. 2589-2593
Authors:
Rabindran, SK
Ross, DD
Doyle, LA
Yang, WD
Greenberger, LM
Citation: Sk. Rabindran et al., Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein, CANCER RES, 60(1), 2000, pp. 47-50
Citation: Dd. Ross et al., Expression of breast cancer resistance protein in blast cells from patients with acute leukemia, BLOOD, 96(1), 2000, pp. 365-368
Authors:
Ross, DD
Yang, WD
Abruzzo, LV
Dalton, WS
Schneider, E
Lage, H
Dietel, M
Greenberger, L
Cole, SPC
Doyle, LA
Citation: Dd. Ross et al., Atypical multidrug resistance: Breast cancer resistance protein messenger RNA expression in mitroxantrone-selected cell lines, J NAT CANC, 91(5), 1999, pp. 429-433
Citation: A. Aszalos et al., Combinations of P-glycoprotein blockers, verapamil, PSC833, and cremophor act differently on the multidrug resistance associated protein (MRP) and onP-glycoprotein (Pgp), ANTICANC R, 19(2A), 1999, pp. 1053-1064
Authors:
Doyle, LA
Yang, WD
Abruzzo, LV
Krogmann, T
Gao, YM
Rishi, AK
Ross, DD
Citation: La. Doyle et al., A multidrug resistance transporter from human MCF-7 breast cancer cells (vol 95, pg 15665, 1998), P NAS US, 96(5), 1999, pp. 2569-2569